More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. and Subsidiary Phyto Animal Health Featured in Top Veterinary Trade Publication

Medical Marijuana, Inc. and Subsidiary Phyto Animal Health Featured in Top Veterinary Trade Publication

by adminAdrianRamirez | Mar 20, 2018 | Press Releases

Leading Veterinary Experts Endorse Company’s Lab Testing Procedures and Certificates of Analysis as the Standard for the Industry SAN DIEGO, March 20, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United...
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces New Fruit-Flavored Energy Kicks

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces New Fruit-Flavored Energy Kicks

by adminAdrianRamirez | Mar 15, 2018 | Press Releases

SAN DIEGO, March 15, 2018  — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary Dixie Botanicals® has released two new flavors of its popular Kicks CBD hemp oil energy chews....
Medical Marijuana, Inc. Subsidiary HempMeds® Brazil and ANUC Host First-Ever Hospital Cannabis Events on the Benefits of CBD in Rio Grande do Sul, Brazil

Medical Marijuana, Inc. Subsidiary HempMeds® Brazil and ANUC Host First-Ever Hospital Cannabis Events on the Benefits of CBD in Rio Grande do Sul, Brazil

by adminAdrianRamirez | Mar 14, 2018 | HempMeds Brasil, Press Releases

SAN DIEGO, March 14, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brazil, which was the first company authorized by Anvisa to import a cannabidiol-based...
Medical Marijuana, Inc. and Subsidiary HempMeds® Mexico Featured in Top 30 U.S. Market Newspaper for Role in Legalizing Mexico Market

Medical Marijuana, Inc. and Subsidiary HempMeds® Mexico Featured in Top 30 U.S. Market Newspaper for Role in Legalizing Mexico Market

by adminAdrianRamirez | Mar 13, 2018 | HempMeds Mexico, Press Releases

SAN DIEGO, March 13, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in a top 30 U.S. market newspaper, Voice of San Diego. A March 12, 2018, article...
Fox 5 News Las Vegas Features Phyto Animal Health at 90th Western Veterinary Conference

Fox 5 News Las Vegas Features Phyto Animal Health at 90th Western Veterinary Conference

by adminAdrianRamirez | Mar 9, 2018 | Media Coverage

Local Fox News affiliate interviews Phyto Animal Health Founder and CEO Ian Quinn about the benefits of CBD for pets at recent Western Veterinary Conference. This past weekend, Las Vegas hosted the 90th Western Veterinary Conference (WVC) annual event at the Mandalay...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.